Journal of Clinical Lipidology

1

Plasma exchange for severe hypertriglyceridemia-induced pancreatitis in an orthotopic heart transplant recipient

Danesh K. Kella, Sana Shoukat, Laurence Sperling

Journal:

Year:

2012

Language:

english

File:

PDF, 92 KB

english, 2012

2

Pseudohypertriglyceridemia: Two cases of probable glycerol kinase deficiency

James M. Backes, Thomas Dayspring, Thomas Mieras, Patrick M. Moriarty

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 220 KB

english, 2012

3

Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglyceride

Yang Yang, Shabbir M. Walijee, Jing Jin, Shui-ping Zhao, Dao-Quan Peng

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 258 KB

english, 2012

4

Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia

Gregory A. Nichols, Bhakti Arondekar, Terry A. Jacobson

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 238 KB

english, 2012

5

EPA and DHA: Distinct yet essential n-3 fatty acids

Seth J. Baum

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

6

Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels

Laurent Querton, Martin Buysschaert, Michel P. Hermans

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 152 KB

english, 2012

7

Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence

Kevin C. Maki, Harold E. Bays, Mary R. Dicklin

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 278 KB

english, 2012

8

Authors' reply to commentary entitled “EPA and DHA: Distinct yet essential n-3 fatty acids”

Terry A. Jacobson, Sara B. Glickstein, Jonathan D. Rowe, Paresh N. Soni

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 87 KB

english, 2012

9

Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein

Allan D. Sniderman, Andre Tremblay, Jacqueline De Graaf, Patrick Couture

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 274 KB

english, 2012

10

The interaction of familial and secondary causes of hypertriglyceridemia: Role in pancreatitis

John D. Brunzell, Helmut G. Schrott

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 380 KB

english, 2012

11

From the Editor: The enigma of hypertriglyceridemia

W. Virgil Brown

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 72 KB

english, 2012

12

Severe hypertriglyceridemia

W. Virgil Brown, John D. Brunzell, Robert H. Eckel, Neil J. Stone

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 213 KB

english, 2012

13

News from the NLA

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 118 KB

english, 2012

14

Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia

Jennifer B. Christian, Bhakti Arondekar, Erin K. Buysman, Susan L. Johnson, John D. Seeger, Terry A. Jacobson

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 927 KB

english, 2012

15

Editorial Board

Journal:

Journal of Clinical Lipidology

Year:

2012

Language:

english

File:

PDF, 89 KB

english, 2012

16

Volume 6; Issue 5

Plasma exchange for severe hypertriglyceridemia-induced pancreatitis in an orthotopic heart transplant recipient

Pseudohypertriglyceridemia: Two cases of probable glycerol kinase deficiency

Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglyceride

Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia

EPA and DHA: Distinct yet essential n-3 fatty acids

Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels

Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence

Authors' reply to commentary entitled “EPA and DHA: Distinct yet essential n-3 fatty acids”

Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein

The interaction of familial and secondary causes of hypertriglyceridemia: Role in pancreatitis

From the Editor: The enigma of hypertriglyceridemia

Severe hypertriglyceridemia

News from the NLA

Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia

Editorial Board

Table of Contents